From: Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
Parameter | Total Cases (N) | E-Cad (Mem) | E-Cad (Cyto) | Slug (Nucl) | Gsk3β (Nucl) | Gsk3β (Cyto) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | + | P | - | + | P | - | + | P | - | + | P | - | + | P | ||
98 | 53 | 45 | 46 | 52 | 65 | 33 | 64 | 34 | 52 | 46 | ||||||
Age | ||||||||||||||||
ὄ 50 | 62 | 30 | 32 | .148 | 24 | 38 | 0.06 | 40 | 22 | .663 | 44 | 18 | 0.131 | 30 | 32 | .294 |
>50 | 36 | 23 | 13 | 22 | 14 | 25 | 11 | 20 | 16 | 22 | 14 | |||||
Menopausal status | ||||||||||||||||
Pre- | 35 | 19 | 16 | 1.00 | 12 | 23 | 0.091 | 22 | 13 | .658 | 27 | 8 | .079 | 19 | 16 | 1.00 |
Post- | 63 | 34 | 29 | 34 | 29 | 43 | 20 | 37 | 26 | 33 | 30 | |||||
Tumor grade | ||||||||||||||||
T1+T2 | 53 | 24 | 29 | .060 | 21 | 32 | 0.155 | 29 | 24 | .01*1 | 29 | 24 | .02*2 | 26 | 27 | .422 |
T3+T4 | 45 | 29 | 16 | 25 | 20 | 36 | 9 | 35 | 10 | 26 | 19 | |||||
Lymphatic involvement | ||||||||||||||||
N0 | 36 | 19 | 17 | 1.00 | 18 | 18 | 0.679 | 22 | 14 | .507 | 20 | 16 | 0.131 | 18 | 18 | .675 |
N1-2 | 62 | 34 | 28 | 28 | 34 | 43 | 19 | 44 | 18 | 34 | 28 | |||||
Grade | ||||||||||||||||
I+II | 56 | 27 | 29 | .221 | 22 | 34 | 0.103 | 33 | 23 | .087 | 32 | 24 | .05*3 | 31 | 25 | .684 |
III+IV | 42 | 26 | 16 | 24 | 18 | 32 | 10 | 32 | 10 | 21 | 21 | |||||
ER | ||||||||||||||||
+ve | 28 | 17 | 11 | .502 | 13 | 15 | 1.00 | 15 | 13 | .103 | 13 | 15 | .019*4 | 17 | 11 | .377 |
-ve | 70 | 36 | 34 | 33 | 37 | 50 | 20 | 51 | 19 | 35 | 35 |